AXSM Annual SG&A
$323.12 M
+$163.87 M+102.90%
31 December 2023
Summary:
As of January 23, 2025, AXSM annual selling, general & administrative expenses is $323.12 million, with the most recent change of +$163.87 million (+102.90%) on December 31, 2023. During the last 3 years, it has risen by +$294.23 million (+1018.20%). AXSM annual SG&A is now at all-time high.AXSM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AXSM Quarterly SG&A
$95.56 M
-$7.99 M-7.72%
30 September 2024
Summary:
As of January 23, 2025, AXSM quarterly selling, general & administrative expenses is $95.56 million, with the most recent change of -$7.99 million (-7.72%) on September 30, 2024. Over the past year, it has increased by +$8.76 million (+10.09%). AXSM quarterly SG&A is now -7.72% below its all-time high of $103.55 million, reached on June 30, 2024.AXSM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AXSM TTM SG&A
-$3.77 B
-$310.95 M-8.99%
30 September 2024
Summary:
As of January 23, 2025, AXSM TTM selling, general & administrative expenses is -$3.77 billion, with the most recent change of -$310.95 million (-8.99%) on September 30, 2024. Over the past year, it has dropped by -$4.09 billion (-1266.94%). AXSM TTM SG&A is now -45720.33% below its all-time high of $384.90 million, reached on September 30, 2024.AXSM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AXSM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +102.9% | +10.1% | -1266.9% |
| 3 y3 years | +1018.2% | +372.5% | -6581.1% |
| 5 y5 years | +3355.3% | +2971.1% | -10000.0% |
AXSM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +384.8% | -7.7% | +407.6% | -163.2% | at low |
| 5 y | 5-year | at high | +2276.3% | -7.7% | +1822.8% | -553.4% | at low |
| alltime | all time | at high | >+9999.0% | -7.7% | >+9999.0% | <-9999.0% | at low |
Axsome Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $95.56 M(-7.7%) | $384.90 M(+3.3%) |
| June 2024 | - | $103.55 M(+4.6%) | $372.52 M(+7.1%) |
| Mar 2024 | - | $98.97 M(+14.0%) | $347.90 M(+7.7%) |
| Dec 2023 | $323.12 M(+102.9%) | $86.81 M(+4.4%) | $323.12 M(+8.5%) |
| Sept 2023 | - | $83.19 M(+5.4%) | $297.81 M(+16.6%) |
| June 2023 | - | $78.94 M(+6.4%) | $255.52 M(+23.0%) |
| Mar 2023 | - | $74.19 M(+20.6%) | $207.74 M(+30.4%) |
| Dec 2022 | $159.25 M(+139.0%) | $61.50 M(+50.4%) | $159.25 M(+36.6%) |
| Sept 2022 | - | $40.89 M(+31.2%) | $116.58 M(+21.5%) |
| June 2022 | - | $31.16 M(+21.2%) | $95.92 M(+18.3%) |
| Mar 2022 | - | $25.70 M(+36.5%) | $81.10 M(+21.7%) |
| Dec 2021 | $66.65 M(+130.6%) | $18.83 M(-6.9%) | $66.65 M(+14.6%) |
| Sept 2021 | - | $20.23 M(+23.8%) | $58.18 M(+31.4%) |
| June 2021 | - | $16.34 M(+45.3%) | $44.28 M(+25.9%) |
| Mar 2021 | - | $11.25 M(+8.6%) | $35.18 M(+21.7%) |
| Dec 2020 | $28.90 M(+112.5%) | $10.36 M(+63.6%) | $28.90 M(+21.6%) |
| Sept 2020 | - | $6.33 M(-12.5%) | $23.76 M(+15.7%) |
| June 2020 | - | $7.24 M(+45.6%) | $20.54 M(+30.4%) |
| Mar 2020 | - | $4.97 M(-4.8%) | $15.75 M(+15.8%) |
| Dec 2019 | $13.60 M | $5.22 M(+67.8%) | $13.60 M(+27.4%) |
| Sept 2019 | - | $3.11 M(+27.3%) | $10.67 M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $2.45 M(-13.2%) | $9.77 M(+0.1%) |
| Mar 2019 | - | $2.82 M(+22.6%) | $9.76 M(+4.4%) |
| Dec 2018 | $9.35 M(+29.8%) | $2.30 M(+4.4%) | $9.35 M(+3.9%) |
| Sept 2018 | - | $2.20 M(-9.7%) | $9.00 M(+4.4%) |
| June 2018 | - | $2.44 M(+1.2%) | $8.63 M(+8.8%) |
| Mar 2018 | - | $2.41 M(+23.6%) | $7.93 M(+10.0%) |
| Dec 2017 | $7.21 M(+13.6%) | $1.95 M(+6.8%) | $7.21 M(+1.9%) |
| Sept 2017 | - | $1.83 M(+4.8%) | $7.08 M(+2.7%) |
| June 2017 | - | $1.74 M(+3.4%) | $6.89 M(+3.2%) |
| Mar 2017 | - | $1.69 M(-7.3%) | $6.67 M(+5.2%) |
| Dec 2016 | $6.34 M(+162.2%) | $1.82 M(+11.0%) | $6.34 M(+15.9%) |
| Sept 2016 | - | $1.64 M(+7.2%) | $5.47 M(+26.3%) |
| June 2016 | - | $1.53 M(+12.7%) | $4.33 M(+32.9%) |
| Mar 2016 | - | $1.36 M(+43.3%) | $3.26 M(+34.7%) |
| Dec 2015 | $2.42 M(+73.7%) | $946.60 K(+89.5%) | $2.42 M(+16.7%) |
| Sept 2015 | - | $499.40 K(+9.4%) | $2.07 M(+5.3%) |
| June 2015 | - | $456.40 K(-11.7%) | $1.97 M(+30.2%) |
| Mar 2015 | - | $516.80 K(-14.0%) | $1.51 M(+51.9%) |
| Dec 2014 | $1.39 M(+357.9%) | $600.80 K(+52.0%) | $996.00 K(+152.0%) |
| Sept 2014 | - | $395.20 K | $395.20 K |
| Dec 2013 | $304.20 K | - | - |
FAQ
- What is Axsome Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Axsome Therapeutics?
- What is Axsome Therapeutics annual SG&A year-on-year change?
- What is Axsome Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly SG&A year-on-year change?
- What is Axsome Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Axsome Therapeutics?
- What is Axsome Therapeutics TTM SG&A year-on-year change?
What is Axsome Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of AXSM is $323.12 M
What is the all time high annual SG&A for Axsome Therapeutics?
Axsome Therapeutics all-time high annual selling, general & administrative expenses is $323.12 M
What is Axsome Therapeutics annual SG&A year-on-year change?
Over the past year, AXSM annual selling, general & administrative expenses has changed by +$163.87 M (+102.90%)
What is Axsome Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of AXSM is $95.56 M
What is the all time high quarterly SG&A for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly selling, general & administrative expenses is $103.55 M
What is Axsome Therapeutics quarterly SG&A year-on-year change?
Over the past year, AXSM quarterly selling, general & administrative expenses has changed by +$8.76 M (+10.09%)
What is Axsome Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of AXSM is -$3.77 B
What is the all time high TTM SG&A for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM selling, general & administrative expenses is $384.90 M
What is Axsome Therapeutics TTM SG&A year-on-year change?
Over the past year, AXSM TTM selling, general & administrative expenses has changed by -$4.09 B (-1266.94%)